Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $96,031 - $123,120
-1,626 Reduced 8.01%
18,685 $1.38 Million
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $378,627 - $568,687
-5,742 Reduced 22.04%
20,311 $1.39 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $682,459 - $1.03 Million
10,888 Added 71.8%
26,053 $2.45 Million
Q1 2023

May 12, 2023

SELL
$47.19 - $70.77 $29,965 - $44,938
-635 Reduced 4.02%
15,165 $1.03 Million
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $479,530 - $839,770
15,800 New
15,800 $782,000
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $246,986 - $339,524
-2,737 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $502,017 - $746,487
-5,360 Reduced 66.2%
2,737 $340,000
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $135,804 - $180,586
1,165 Added 16.81%
8,097 $1.07 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $690,496 - $985,175
6,932 New
6,932 $918,000
Q3 2020

Nov 12, 2020

SELL
$72.92 - $102.01 $318,660 - $445,783
-4,370 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $89,088 - $148,214
-1,598 Reduced 26.78%
4,370 $380,000
Q1 2020

May 12, 2020

SELL
$37.9 - $104.44 $104,262 - $287,314
-2,751 Reduced 31.55%
5,968 $346,000
Q4 2019

Feb 11, 2020

BUY
$77.66 - $99.74 $279,808 - $359,363
3,603 Added 70.43%
8,719 $806,000
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $23,315 - $31,602
258 Added 5.31%
5,116 $462,000
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $278,286 - $366,986
-3,109 Reduced 39.02%
4,858 $573,000
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $1.64 Million - $2.55 Million
-26,466 Reduced 76.86%
7,967 $690,000
Q4 2018

Feb 13, 2019

SELL
$56.04 - $82.66 $754,018 - $1.11 Million
-13,455 Reduced 28.1%
34,433 $2.17 Million
Q3 2018

Nov 13, 2018

SELL
$48.29 - $80.6 $1.29 Million - $2.15 Million
-26,643 Reduced 35.75%
47,888 $3.78 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $754,680 - $1.4 Million
-19,944 Reduced 21.11%
74,531 $4.46 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $500,179 - $722,634
12,561 Added 15.33%
94,475 $3.81 Million
Q4 2017

Feb 08, 2018

SELL
$46.49 - $60.51 $1.49 Million - $1.93 Million
-31,948 Reduced 28.06%
81,914 $4.3 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $4.22 Million - $5.37 Million
113,862
113,862 $5.37 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.